ZURICH (Reuters) - Swiss drugmaker Novartis AG on Tuesday stuck to its outlook for lower profitability this year, as a stoppage at a U.S. manufacturing site and tough annual comparisons for its Sandoz division hit first-quarter core earnings.

Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/TFAlYKuDLkI/us-novartis-idUSBRE83N06520120424
Current news latest news top news recent news save money travel
No comments:
Post a Comment